Skip to main content
News

HHS to allow sale of unapproved peptides under review

HHS to allow sale of unapproved peptides under review

Feed excerpt — reported by The Hill

The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to the those championed by the Make America Healthy Again (MAHA) agenda. HHS stated in a notice that it would be practicing enforcement discretion…

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at The Hill →

Original Source

This article was syndicated from The Hill. All rights remain with the original publisher.